nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Applying Risk-Based Follow-Up Strategies on the Dutch Breast Cancer Population: Consequences for Care and Costs
|
Draeger, Teresa |
|
|
23 |
9 |
p. 1149-1156 |
artikel |
2 |
Are Unit Costs the Same? A Case Study Comparing Different Valuation Methods for Unit Cost Calculation of General Practitioner Consultations
|
Mayer, Susanne |
|
|
23 |
9 |
p. 1142-1148 |
artikel |
3 |
A Review of Methodological Considerations for Economic Evaluations of Gene Therapies and Their Application in Literature
|
ten Ham, Renske M.T. |
|
|
23 |
9 |
p. 1268-1280 |
artikel |
4 |
Are We Making a Difference? A Qualitative Study of Patient Engagement at the pan-Canadian Oncology Drug Review: Perspectives of Patient Groups
|
Mercer, Rebecca E. |
|
|
23 |
9 |
p. 1157-1162 |
artikel |
5 |
Association Between Medication Adherence and Healthcare Costs Among Patients Receiving the Low-Income Subsidy
|
Qiao, Yanru |
|
|
23 |
9 |
p. 1210-1217 |
artikel |
6 |
Competencies for Professionals in Health Economics and Outcomes Research: The ISPOR Health Economics and Outcomes Research Competencies Framework
|
Pizzi, Laura T. |
|
|
23 |
9 |
p. 1120-1127 |
artikel |
7 |
Copyright/Subscription
|
|
|
|
23 |
9 |
p. v |
artikel |
8 |
Cost-Utility Analysis of Direct-Acting Antivirals for Treatment of Chronic Hepatitis C Genotype 1 and 6 in Vietnam
|
Due, Ong The |
|
|
23 |
9 |
p. 1180-1190 |
artikel |
9 |
Demand for Cancer Screening Services: Results From Randomized Controlled Discrete Choice Experiments
|
Bilger, Marcel |
|
|
23 |
9 |
p. 1246-1255 |
artikel |
10 |
Editorial Board
|
|
|
|
23 |
9 |
p. vi |
artikel |
11 |
Effect of Case-Mix and Random Variation on Breast Cancer Care Quality Indicators and Their Rankability
|
Vos, Elvira L. |
|
|
23 |
9 |
p. 1191-1199 |
artikel |
12 |
Evaluating the Ability of Economic Models of Diabetes to Simulate New Cardiovascular Outcomes Trials: A Report on the Ninth Mount Hood Diabetes Challenge
|
Si, Lei |
|
|
23 |
9 |
p. 1163-1170 |
artikel |
13 |
Evaluating the Use of microRNA Blood Tests for Gastric Cancer Screening in a Stratified Population-Level Screening Program: An Early Model-Based Cost-Effectiveness Analysis
|
Kapoor, Ritika |
|
|
23 |
9 |
p. 1171-1179 |
artikel |
14 |
From Multiple Quality Indicators of Breast Cancer Care Toward Hospital Variation of a Summary Measure
|
Vos, Elvira L. |
|
|
23 |
9 |
p. 1200-1209 |
artikel |
15 |
Health State Utility Values in Schizophrenia: A Systematic Review and Meta-Analysis
|
Aceituno, David |
|
|
23 |
9 |
p. 1256-1267 |
artikel |
16 |
Improving Transparency to Build Trust in Real-World Secondary Data Studies for Hypothesis Testing—Why, What, and How: Recommendations and a Road Map from the Real-World Evidence Transparency Initiative
|
Orsini, Lucinda S. |
|
|
23 |
9 |
p. 1128-1136 |
artikel |
17 |
Nephrologist Follow-Up Care of Patients With Acute Kidney Disease Improves Outcomes: Taiwan Experience
|
Wu, Vin-Cent |
|
|
23 |
9 |
p. 1225-1234 |
artikel |
18 |
Parallel Valuation of the EQ-5D-3L and EQ-5D-5L by Time Trade-Off in Hungary
|
Rencz, Fanni |
|
|
23 |
9 |
p. 1235-1245 |
artikel |
19 |
Spending on Hepatitis C Antivirals in the United States and Canada, 2014 to 2018
|
Shakeri, Ahmad |
|
|
23 |
9 |
p. 1137-1141 |
artikel |
20 |
Table of Contents
|
|
|
|
23 |
9 |
p. i-iv |
artikel |
21 |
Taking Steps Toward Transparency in Real-World Evidence Studies
|
Drummond, Michael F. |
|
|
23 |
9 |
p. 1119 |
artikel |
22 |
What Is a Valid Mapping Algorithm in Cost-Utility Analyses? A Response From a Missing Data Perspective
|
Hagiwara, Yasuhiro |
|
|
23 |
9 |
p. 1218-1224 |
artikel |